The Bright Idea...

Improved Test for Bladder Cancer

Each year in Europe, there are over 150,000 bladder cancer diagnoses, around 10,000 of which are in the UK alone. With the highest lifetime treatment costs per patient of all cancers, the high incidence of bladder cancer and a recurrence rate of 65% in the first two years, places an enormous burden upon healthcare systems across Europe.

Cytoscopy, a costly surgical technique, is currently considered to be the gold-standard diagnostic tool for bladder cancer. Despite this, up to 30% of cancers are missed at the initial cystoscopy stage, and the technique is very uncomfortable for the patient, with a high risk of infection. The team at Sunderland Clinical Commissioning Group have developed a test for bladder cancer diagnosis which is accurate and simple to execute, without subjecting the patient to the discomfort of an invasive test.

The Innovators...

Nadia Whittley, CEO
Arquer Diagnostics Ltd.

Stuart McCracken, Consultant Urologist and Sue Asterling, Urology Nurse Sunderland Royal Hospital

Jo Cresswell, Consultant Urologist, Dawn Watson and Claire Proctor, Urology Research Nurses
James Cook University Hospital

Mr. Jaswant Mom, Consultant Urologist,
Cumberland Infirmary and West Cumberland Hospital

Grace Fryer, Research Practitioner
Cumberland Infirmary

Hannah Crowther, Research Practitioner and team
West Cumberland Hospital

Mr Tim Dudderidge, Consultant Urological Surgeon
University Hospitals Southampton NHS Foundation Trust

Mr Ghulam Nabi, Consultant and Senior Clinical Lecturer in
Surgical Uro-oncology

Ninewells Hospital, NHS Tayside

Mr. David Hrouda, Consultant Urologist
Charing Cross Hospital, Imperial College Healthcare NHS Trust

The Bright Idea...

Central Venous Line Fall-Out Prevention in Renal Patients

Approximately 12,500 adult haemodialysis patients in the UK are fitted with a central venous catheter (CVC), but accidental line fall out occurs in around 20% of these patients at an average cost to the NHS of £3,000 for every incidence. Led by City Hospitals Sunderland NHS Foundation Trust, a collaboration between patients, The National Institute of Health Research Clinical Research Network: North East and North Cumbria (NIHR CRN NENC), MedConnecT North, NIHR Devices for Dignity HTC, TITCH (Technology Innovation Transforming Child Health), and Tookie Limited, has resulted in the development of a solution to prevent CVC fall out, which discretely and comfortably maintains the CVC safely in place whilst ensuring that the patient can lead a life more normal. The patient’s quality of life is improved, and the mechanisms which enable the efficient delivery of their treatment are made more efficient.

The Innovators...

Stephen Tooke, Commercial Director
David Axon, CEO
Tookie Ltd

Dr. Saeed Ahmed, Consultant Interventional Nephrologist
Dr. Rachel Davison, Consultant in Renal Medicine
Debbie Sweeney, Vascular Access Specialist Nurse
Paul Corrigan, Research Nurse
City Hospitals Sunderland NHS Foundation Trust

Mark Taylor, MedCoNecTNorth
NIHR Clinical Research Network, North East and North Cumbria

The Bright Idea...

Structured Digital Prescriptions for Orthotics

Prescribing custom orthotics is a complex procedure and one that to date has been carried out using traditional pen and paper. This approach can lead to incorrect prescriptions, or prescriptions that are missing vital data. These errors and omissions lead to delays in treatment as well as increasing costs as a result of the processing of corrections. The team at Peacocks has developed an innovative piece of software which results in accurate repeatability, improved patient experience, cost savings, and a reduction in errors.

The Innovators…

David Stevens, Managing Director
Mark Turner, Commercial Director
Peter Fullarton, Head of Information Technology
Cameron Hall, Orthotic Clinical Lead
Peacocks Medical Group